Seeking Alpha

Tal Ben-Ami

 
View as an RSS Feed
View Tal Ben-Ami's Articles BY TICKER:
  • Ampio's Ampion - Strong Positives With Clear Risks
    Fri, May. 2 AMPE 36 Comments

    Summary

    • Data for Ampion's Phase 3 is due around July. Ampion is Ampio's albumin-based candidate for osteoarthritis treatment.
    • The FDA has already made positive hints towards approval, calling the data already available "robust" and "sufficient".
    • Despite these obvious positives, the risks are clear. Some positives may already be priced in, and other companies marketing new osteoarthritis treatments have had slow sales to start.
    • The stock will jump higher assuming approval, but longer term it can go either way.
  • MetaStat's Innovative Oncology Approach: Stop Metastasis, Stop The Cancer
    Thu, Mar. 6 MTST Comment!

    Summary

    • 90% of all cancer deaths are a result of metastasis. MetaStat seeks to change the way cancer is treated by managing and preventing metastasis instead of attacking cancer directly.
    • MetaStat has both diagnostic and therapeutic candidates in its pipeline, with large diagnostic trials underway and on a timeline of 2015 CLIA approval, and therapeutics around 2018.
    • While MetaStat's therapeutics are more speculative, its CLIA diagnostics have the potential for market penetration of over 600,000 cases per year, which could more than double its current market cap.
  • Academic Support Boosts Agenus And Prophage G-200
    Mon, Feb. 10 AGEN 8 Comments
  • An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases
    Tue, Jan. 7 SGMO, AMBS, PJP 9 Comments
  • Why Positive Results For Cohort 3 Had Counterintuitive Effect On Senesco
       • Dec. 10, 2013 SNTI 15 Comments
  • Biozone: An In-Depth Look In Light Of Recent Investments
    Oct. 9, 2013 COCP 38 Comments
  • An Opportunity For International Exposure To An All-American Institution
    Sep. 4, 2013 HOTR Comment!
  • Ecotality May Have Failed, But The EV Industry Has Not
    Aug. 26, 2013 ECTYQ 15 Comments
  • Membership Has Its Privileges: The Upside Of Joining The Indexes
    Jun. 29, 2013 EGPT, GM, GREK 5 Comments
  • Biodefense: Live By Government Contracts, Die By Government Contracts
    May. 12, 2013 EBS, LMT, NOC 2 Comments
  • Don't Fight The Health Care Current, Swim With The Urgent Care Tide
    Apr. 8, 2013 CVS, HUM, WAG 2 Comments
  • A Short History Of Commodity Bulls; Why This One May Be Different
    Feb. 18, 2013 DBA, DE, GIS 19 Comments
  • Mobile Advertising Transforms The Entire Advertising Market
    Feb. 11, 2013 FB, MFON, SONC Comment!